Similar articles

• Haloperidol dosing strategies.

  Volavka J. Volavka J. Am J Psychiatry. 1996 Aug;153(8):1108; author reply 1109. Am J Psychiatry. 1996. PMID: 8678186 No abstract available.
• Monitoring of haloperidol serum levels and it's clinical significance.

  Itoh H, Yagi G, Tateyama M, Fujii Y, Iwamura K, Ichikawa K. Itoh H, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(1):51-62. doi: 10.1016/0278-5846(84)90135-0. Prog Neuropsychopharmacol Biol Psychiatry. 1984. PMID: 6539490
• Pharmacokinetic parameters of bromperidol in Korean subjects.

  Lee SY, Kim YG, Kim HG, Kim JW. Lee SY, et al. Hum Psychopharmacol. 2006 Aug;21(6):409-12. doi: 10.1002/hup.776. Hum Psychopharmacol. 2006. PMID: 16915578 Clinical Trial.
• Torsade de pointes and low-dose oral haloperidol.

  Jackson T, Ditmanson L, Phibbs B. Jackson T, et al. Arch Intern Med. 1997 Sep 22;157(17):2013-5. Arch Intern Med. 1997. PMID: 9308514 Review.
• [The "neuroleptic threshold"--a review of the literature].

  Abraham D, Kissling W, Lauter H. Abraham D, et al. Psychiatr Prax. 1996 May;23(3):109-16. Psychiatr Prax. 1996. PMID: 8710999 Review. German.